HLN
NYSE HealthcareHaleon plc
$9.28
-$0.08 (-0.85%)
Live quote
52w: $8.65 – $11.28
Loading chart…
P/E Ratio—
P/B Ratio—
EV/EBITDA—
Debt/Equity—
ROE—
ROIC—
Revenue Growth—
Gross Margin—
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.
Own HLN? Track it here.
Create a free account to add HLN to a portfolio and watch your P/L update in real time.
Custom screens, valuation models and backtesting are coming to Pro.